IMU 4.00% 4.8¢ imugene limited

Ann: Azer-cel Hits Major Milestone in Phase 1b CAR T Trial, page-183

  1. 3,405 Posts.
    lightbulb Created with Sketch. 289
    you do know that they have got to release information when it becomes available … no picking and choosing.
    HQs main game is the survival of patients, not investors intra-day gains.
    the share price remains strong on the weekly.
    I’m not surprised by the pullback given the week we’ve had, and with continual expected news flow from here to the end of 2024, there’s plenty to look forward to.
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.